Physician profile
Daniel E Kleiner
NPI 1033324496
$513.54
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $49.17 · 2021: $94.98 · 2022: $20.53 · 2023: $16.56 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $189.52 | 2021-2024 | Renasys Touch, Pico 7 |
| Taiho Oncology, INC. | $48.17 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $35.32 | 2020 | |
| Array Biopharma INC | $32.88 | 2019 | |
| Sirtex Medical INC | $32.44 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $30.41 | 2019 | |
| Medtronic, INC. | $27.61 | 2021 | |
| Amag Pharmaceuticals, INC. | $20.77 | 2019 | |
| Heron Therapeutics, INC. | $19.18 | 2021 | |
| Csl Behring | $18.24 | 2021 | |
| Exelixis INC. | $16.77 | 2019 | |
| Erbe USA INC | $16.28 | 2019 | |
| Lilly USA, LLC | $13.85 | 2020 | |
| Davol INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kleiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.